Drug Shortage Report for MULTI-12/K1 PEDIATRIC
| Report ID | 172557 |
| Drug Identification Number | 02242529 |
| Brand name | MULTI-12/K1 PEDIATRIC |
| Common or Proper name | MULTI-12/K1 PED |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | VITAMIN D VITAMIN A ASCORBIC ACID VITAMIN B12 FOLIC ACID BIOTIN VITAMIN K1 VITAMIN E DEXPANTHENOL NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE VITAMIN B2 VITAMIN B1 |
| Strength(s) | 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | SINGLE DOSE 10LIVI |
| ATC code | B05XC |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-28 |
| Estimated end date | 2023-05-26 |
| Actual end date | 2023-05-19 |
| Shortage status | Resolved |
| Updated date | 2023-05-30 |
| Company comments | Baxter item : 6461 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.